Older age is the main risk factor for cancer. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors.
This page covers other factors with the best evidence of an association with cancer risk; this list is not exhaustive.
*These statistics are aimed at supporting health professionals, academics, researchers and media. If you are a patient or carer, you may want to visit our public facing webpages.
The following preventable cases statistics are for 2015. Updated preventable cases statistics will be available here by early-2027.
91% of anal cancer cases in the UK in 2015 were, in theory, preventable through removal of risk factor exposure at population level, it is estimated. Exposure to certain infections accounts for all of these preventable cases of anal cancer.
91% of anal cancer cases in the UK are caused by HPV infection. Around 91% of anal cancers in women and 75% in men are HPV-positive, a meta-analysis showed.
Sexual activity increases risk of HPV infection for people of any gender. Based on studies of men who reached adolescence before the HPV vaccine was routinely offered, anal cancer risk is higher in men who have sex with men (MSM), compared with the general population.
Read more in our health information on infections, HPV and cancer.
91% of anal cancer cases in the UK are caused by HPV infection. Around 91% of anal cancers in women and 75% in men are HPV-positive, a meta-analysis showed.
Sexual activity increases risk of HPV infection for people of any gender. Based on studies of men who reached adolescence before the HPV vaccine was routinely offered, anal cancer risk is higher in men who have sex with men (MSM), compared with the general population.
Anal cancer risk may be higher in smokers compared with non-smokers; the association is probably independent of other risk factors including human papillomavirus (HPV) infection, and may reflect an immunosuppressive effect of smoking.
Risk factors last reviewed: 20 December 2024
Discover our latest cancer statistics for each cancer type including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, diagnosis and treatment.
Browse our cancer statistics A-ZFind information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.
Go to local cancer statistics - search profiles by area, constituency or health board in the UK.
You are welcome to reuse this Cancer Research UK content for your own work. When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or follow the link to donate online.
Donate onlineWe are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used.
Find out more about the sources which are essential for our statistics
Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018.
De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124(7):1626-36.
Vaccarella S, Franceschi S, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiology Biomarkers & Prevention 2006;;15(2):326-33.
Clifford GM, et al. A meta‐analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale. Int J Cancer 2021;148(1):38-47.
Grulich AE, Poynten IM, Machalek DA, et al. The epidemiology of anal cancer. Sex Health. 2012 Dec;9(6):504-8.